Wall Street brokerages forecast that Biogen Inc. (NASDAQ:BIIB) will report sales of $2.61 billion for the current fiscal quarter, according to Zacks Investment Research. Thirty analysts have made estimates for Biogen’s earnings, with estimates ranging from $2.46 billion to $2.76 billion. Biogen posted sales of $3.68 billion in the same quarter last year, which suggests […]
